Skip to main content

PAVmed Inc.

PAVM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001624326

No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding PAVmed Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of PAVM: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6158−3
Shares10.0M9.27M−768.4K (−7.7%)
Value$3.76M$3.78M+$18.8K (+0.5%)

New holders (4)

Institutions that held PAVmed Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to PAVM in Q2 2023
InstitutionSharesValue% of portfolio
Lazari Capital Management, Inc.89,000$36.3K0.02%
Charles Schwab Investment Management Inc79,503$32.4K0.00%
Victory Capital Management Inc10,187$4.15K0.00%
Wolverine Asset Management LLC110$440.00%

Sold out (7)

Institutions that held PAVmed Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of PAVM in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Jane Street Group, LLC56,292$21.0K
Virtu Financial LLC32,631$12.0K
Commonwealth Equity Services, LLC16,065$6.00K
Financial Advocates Investment Management14,656$5.47K
TCI Wealth Advisors, Inc.601$225
FMR LLC500$187
Lumature Wealth Partners, LLC14$5